Citation: Mg. Cormican et al., AVOPARCIN, A GLYCOPEPTIDE USED IN ANIMAL FOODS - ANTIMICROBIAL SPECTRUM AND POTENCY TESTED AGAINST HUMAN ISOLATES FROM THE UNITED-STATES, Diagnostic microbiology and infectious disease, 29(4), 1997, pp. 241-248
Citation: Mg. Cormican et Rn. Jones, ANTIMICROBIAL ACTIVITY AND SPECTRUM OF LB20304, A NOVEL FLUORONAPHTHYRIDONE, Antimicrobial agents and chemotherapy, 41(1), 1997, pp. 204-211
Authors:
GLENNON M
CORMICAN MG
RIAIN UN
HEGINBOTHOM M
GANNON F
SMITH T
Citation: M. Glennon et al., A MYCOBACTERIUM MALMOENSE-SPECIFIC DNA-PROBE FROM THE 16S 23S RIBOSOMAL-RNA INTERGENIC SPACER REGION/, Molecular and cellular probes, 10(5), 1996, pp. 337-345
Citation: Rn. Jones et al., CLINDAMYCIN RESISTANCE AMONG ERYTHROMYCIN-RESISTANT STREPTOCOCCUS-PNEUMONIAE, Diagnostic microbiology and infectious disease, 25(4), 1996, pp. 201-204
Authors:
CORMICAN MG
WILKE WW
BARRETT MS
PFALLER MA
JONES RN
Citation: Mg. Cormican et al., PHENOTYPIC DETECTION OF MEC A-POSITIVE STAPHYLOCOCCAL BLOOD-STREAM ISOLATES - HIGH-ACCURACY OF SIMPLE DISK DIFFUSION TESTS, Diagnostic microbiology and infectious disease, 25(3), 1996, pp. 107-112
Citation: Mg. Cormican et al., DNA MACRORESTRICTION PROFILES AND ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA (TORULOPSIS) GLABRATA, Diagnostic microbiology and infectious disease, 25(2), 1996, pp. 83-87
Authors:
CORMICAN MG
ERWIN ME
MARSHALL SA
JONES RN
Citation: Mg. Cormican et al., SUSCEPTIBILITY TESTING INTERPRETIVE CRITERIA FOR LEVOFLOXACIN WHEN TESTING RESPIRATORY PATHOGENS, HAEMOPHILUS-INFLUENZAE AND MORAXELLA-CATARRHALIS, Diagnostic microbiology and infectious disease, 24(3), 1996, pp. 155-160
Citation: Mg. Cormican et al., MULTICENTER VALIDATION OF PROPOSED DISK DIFFUSION SUSCEPTIBILITY TESTING INTERPRETIVE CRITERIA FOR LOMEFLOXACIN USING MORE THAN 1,500 CLINICAL ISOLATES, Diagnostic microbiology and infectious disease, 24(3), 1996, pp. 169-172
Citation: Mg. Cormican et al., FALSE RESISTANCE TO METRONIDAZOLE BY E-TEST AMONG ANAEROBIC-BACTERIA INVESTIGATIONS OF CONTRIBUTING TEST CONDITIONS AND MEDIUM QUALITY, Diagnostic microbiology and infectious disease, 24(2), 1996, pp. 117-119
Citation: Mg. Cormican et al., ACTIVITY OF THE QUINUPRISTIN-DALFOPRISTIN COMBINATION (RP-59500 SYNERCID) TESTED AGAINST VANCOMYCIN-RESISTANT ENTEROCOCCUS SPECIES, Diagnostic microbiology and infectious disease, 24(1), 1996, pp. 59-60
Citation: Mg. Cormican et Ma. Pfaller, STANDARDIZATION OF ANTIFUNGAL SUSCEPTIBILITY TESTING, Journal of antimicrobial chemotherapy, 38(4), 1996, pp. 561-578
Citation: Mg. Cormican et Rn. Jones, IN-VITRO ACTIVITY OF TROVAFLOXACIN (CP99,219) TESTED BY 2 METHODS AGAINST 150 VANCOMYCIN-RESISTANT ENTEROCOCCAL ISOLATES, Journal of antimicrobial chemotherapy, 37(4), 1996, pp. 847-849
Citation: Mg. Cormican et al., DETECTION OF EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL)-PRODUCING STRAINS BY THE ETEST ESBL SCREEN, Journal of clinical microbiology, 34(8), 1996, pp. 1880-1884
Citation: Mg. Cormican et Rn. Jones, EMERGING RESISTANCE TO ANTIMICROBIAL AGENTS IN GRAM-POSITIVE BACTERIA- ENTEROCOCCI, STAPHYLOCOCCI AND NONPNEUMOCOCCAL STREPTOCOCCI, Drugs, 51, 1996, pp. 6-12
Authors:
APPELBAUM PC
CORMICAN MG
JONES RN
VANNUFFEL P
COCITO C
PECHERE JC
FINCH RG
RUBINSTEIN E
Citation: Pc. Appelbaum et al., NEW STRATEGIES IN INFECTIOUS-DISEASES - RATIONALE FOR THE USE OF NOVEL STREPTOGRAMINS - A SEMINAR-IN-PRINT - QUESTIONS AND ANSWERS, Drugs, 51, 1996, pp. 43-45
Citation: Mg. Cormican et al., IN-VITRO ACTIVITY OF LEVOFLOXACIN AND FK-037 AGAINST AEROBIC ISOLATESFROM SPONTANEOUS BACTERIAL PERITONITIS, Journal of chemotherapy, 7(3), 1995, pp. 197-200
Citation: Mg. Cormican et al., PRELIMINARY INTERPRETIVE CRITERIA FOR DISK DIFFUSION SUSCEPTIBILITY TESTING OF SCH-27899, A COMPOUND IN THE EVERNINOMICIN CLASS OF ANTIMICROBIAL AGENTS, Diagnostic microbiology and infectious disease, 23(4), 1995, pp. 157-160
Authors:
CORMICAN MG
GLENNON M
NIRIAIN U
SMITH T
FLYNN J
GANNON F
Citation: Mg. Cormican et al., EVALUATION OF A PCR ASSAY FOR DETECTION OF MYCOBACTERIUM-TUBERCULOSISIN CLINICAL SPECIMENS, Diagnostic microbiology and infectious disease, 22(4), 1995, pp. 357-360
Citation: Mg. Cormican et Rn. Jones, ANTIMICROBIAL ACTIVITY OF CEFOTAXIME TESTED AGAINST INFREQUENTLY ISOLATED PATHOGENIC SPECIES (UNUSUAL PATHOGENS), Diagnostic microbiology and infectious disease, 22(1-2), 1995, pp. 43-48
Citation: Mg. Cormican et al., BACTERICIDAL ACTIVITY OF CEFOTAXIME, DESACETYLCEFOTAXIME, RIFAMPIN, AND VARIOUS COMBINATIONS TESTED AT CEREBROSPINAL-FLUID LEVELS AGAINST PENICILLIN-RESISTANT STREPTOCOCCUS-PNEUMONIAE, Diagnostic microbiology and infectious disease, 22(1-2), 1995, pp. 119-123
Citation: Mg. Cormican et Rn. Jones, REEVALUATIONS OF DISK DIFFUSION SUSCEPTIBILITY TESTING INTERPRETIVE CRITERIA FOR LOMEFLOXACIN AND NORFLOXACIN USING FLUOROQUINOLONE-RESISTANT ISOLATES, Diagnostic microbiology and infectious disease, 21(4), 1995, pp. 227-230
Citation: Mg. Cormican et al., CROSS-RESISTANCE ANALYSIS FOR DU-6859A, A NEW FLUOROQUINOLONE, COMPARED TO 6 STRUCTURALLY SIMILAR COMPOUNDS (CIPROFLOXACIN, CLINAFLOXACIN, FLEROXACIN, LEVOFLOXACIN, OFLOXACIN, AND SPARFLOXACIN), Diagnostic microbiology and infectious disease, 21(1), 1995, pp. 51-54
Citation: Mg. Cormican et Rn. Jones, CROSS-RESISTANCE ANALYSIS FOR CLINAFLOXACIN COMPARED WITH CIPROFLOXACIN, FLEROXACIN, OFLOXACIN, AND SPARFLOXACIN USING A PREDICTOR PANEL OFCIPROFLOXACIN-RESISTANT BACTERIA, Journal of antimicrobial chemotherapy, 36(2), 1995, pp. 431-434
Citation: Mg. Cormican et Rn. Jones, EVALUATION OF THE IN-VITRO ACTIVITY OF FUROPENEM (SY5555 OR SUN5555) AGAINST RESPIRATORY-TRACT PATHOGENS AND BETA-LACTAMASE-PRODUCING BACTERIA, Journal of antimicrobial chemotherapy, 35(4), 1995, pp. 535-539
Citation: Mg. Cormican et Rn. Jones, USE OF A MULTIPLEX PCR TO DETECT AND IDENTIFY MYCOBACTERIUM-AVIUM ANDMYCOBACTERIUM-INTRACELLULARE IN BLOOD CULTURE FLUIDS OF AIDS PATIENTS, Journal of clinical microbiology, 33(8), 1995, pp. 2230-2230